Two Harvard stem-cell scientists are teaming up with a German biotech company to expand the search for a cure for Lou Gehrig’s Disease. Kevin Eggan and Lee Rubin, both professors of stem cell and regenerative biology at the Harvard Stem Cell Institute, will conduct amyotrophic lateral sclerosis trials in partnership with Evotec, the university and the company announced.

Read full article